HT Simonsen Holding ApS: Financial statements 2025
CVR: 37334308
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
HT Simonsen Holding ApS (CVR 37334308) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -990 and a net result of DKK -990 compared with DKK -477 the year before. Equity in the 2025 report amounted to DKK 12,465. The solvency ratio was 100%.
- Gross Profit
- DKK -990
- Profit/Loss
- DKK -990
- Equity
- DKK 12,465
- Total Assets
- DKK 12,465
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -990 | -990 | 12 t. | 0 |
| 2024 | - | -477 | -477 | 15 t. | 0 |
| 2023 | 5 t. | 202 | 5 t. | 23 t. | - |
| 2022 | 0 | -10 t. | -10 t. | 31 t. | - |
| 2021 | - | -2 t. | 13 t. | 48 t. | - |
Official annual report
How creditworthy is HT Simonsen Holding ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
HT Simonsen Holding ApS has published its annual report for 2024. Gross profit came to DKK -477, and the net result was DKK -477.
About HT Simonsen Holding ApS
HT Simonsen Holding ApS is a Danish company of the type Anpartsselskab based in Glostrup, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named HT Simonsen Holding IVS and Mosspiration Biotech IVS. The management consists of Henrik Toft Simonsen. The company is owned by Henrik Toft Simonsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -990 and a net result of DKK -990 compared with DKK -477 the year before. Equity in the 2025 report amounted to DKK 12,465.